BPC3 Consortium Members
Overview of Cohorts in the BPC3
The table below briefly summarizes information about the participating cohorts in the BPC3. These cohorts had accrued >500 cases of invasive breast and/or >500 cases of prostate cancer. All of the cohorts are supported by funding independent of the BPC3 Study.
| Cohort | Year Cohort Established | Principal Investigator of BPC3/Institution |
|---|---|---|
| American Cancer Society (CPS-II) | 1998 | Susan Gapstur, Ph.D., M.P.H. American Cancer Society |
| European Prospective Investigation Into Cancer and Nutrition (EPIC) | 1992 | Elio Riboli, M.D., M.P.H., M.Sc. Imperial College, London |
| Physicians' Health Study (PHS) I* | 1982 | David J. Hunter, M.B.B.S., Sc.D. Channing Laboratory, Harvard School of Public Health |
| Nurses' Health Study (NHS) I* | 1976 | |
| Nurses' Health Study (NHS) II* | 1989 | |
| Health Professionals Follow-up Study (HPFS)* | 1993 | |
| Women's Health Study (WHS) | 1993 | Julie Buring, Sc.D. Harvard School of Public Health |
| Multiethnic Cohort (MEC) Study of Diet and Cancer | 1993 | Brian E. Henderson, M.D. University of Southern California |
| Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)* | 1993 | Robert Hoover, M.D., Sc.D. National Cancer Institute |
| Alpha-Tocopherol Beta-Carotene (ATBC) Study | 1991 | Demetrius Albanes, M.D. National Cancer Institute |
* In this instance, the principal investigator for the cohort differs from the principal investigator for the BPC3.
BPC3 Steering Committee
To achieve the goals of the consortium, a Steering Committee coordinates the efforts within and across the participating cohorts and scientific disciplines. The Steering Committee includes the four principal investigators for the cooperative agreements that fund participation of the cohorts in the BCP3 Study, the principal investigators of the cohorts themselves (which are funded independent of this study), and NCI Program staff as Ex Officio members. The Steering Committee coordinates the activities of the research components, decides on a timeline for specific subcomponents of the study (e.g., the order in which groups of genes are genotyped), coordinates pooling of data, and distributes parts of the pooled data analyses to BCP3 Study members.
